D. E. Shaw & Co., Inc. Jazz Pharmaceuticals PLC Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
A detailed history of D. E. Shaw & Co., Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,906 shares of JAZZ stock, worth $442,666. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,906
Previous 66,191
94.1%
Holding current value
$442,666
Previous $8.22 Million
94.96%
% of portfolio
0.0%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding JAZZ
# of Institutions
557Shares Held
62.7MCall Options Held
559KPut Options Held
74.5K-
Black Rock Inc. New York, NY6.15MShares$696 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$690 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$289 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$288 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$288 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.1B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...